Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. FDA
Biotech
Lykos' MDMA treatment for PTSD has been quashed at the FDA
Following a poor showing for Lykos' MDMA candidate in post-traumatic stress disorder at an FDA expert meeting, the other shoe has dropped.
Fraiser Kansteiner
Aug 10, 2024 9:07am
FDA's Richard Pazdur explains confirmatory trial rejection, more
Apr 8, 2024 6:00am
Peter Marks says FDA ready to review novel cancer vaccines
Apr 3, 2024 2:39pm
'The Top Line': Unraveling Alzheimer's disease treatments
Oct 13, 2023 6:00am
Panel of FDA experts endorses Pfizer's RSV vaccine prospect
Feb 28, 2023 4:59pm
FDA looks to bypass cancer drugs' companion diagnostics: Pazdur
Nov 18, 2022 9:17am
